Protection from clinical varicella disease during interferon alpha-2a therapy for chronic active hepatitis B infection

Pediatr Infect Dis J. 1997 Jul;16(7):720-2. doi: 10.1097/00006454-199707000-00021.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Chickenpox / prevention & control*
  • Hepatitis B / therapy*
  • Hepatitis, Chronic / therapy*
  • Humans
  • Infant
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Male
  • Recombinant Proteins

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins